Anna Eramo - Chief Medical Officer at LB PHARMACEUTICALS INC

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
LBRX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Anna Eramo since 03 Aug 2025

Reported holdings for Anna Eramo in LB PHARMACEUTICALS INC

Form 4 holding Chief Medical Officer

LB PHARMACEUTICALS INC

Security class
Employee Stock Option (Right to Buy)
Shares / value
155,812
Estimated value
Report date
10 Sep 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

LB PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
3,585
Estimated value
Report date
10 Sep 2025
Price
Ownership
Direct

Transaction history for Anna Eramo in LB PHARMACEUTICALS INC

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .